Assessment and management of comorbidities (including cardiovascular disease) in patients with nonalcoholic fatty liver disease
Clinical Liver Disease. 2012;1(4):114-116 
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation
Liver Transplantation. 2018;24(2):166-170
Management of nonalcoholic fatty liver disease in children
Clinical Liver Disease. 2012;1(4):129-130
Nonalcoholic fatty liver disease and non-liver comorbidities
Clinical and Molecular Hepatology. 2023;29(Suppl):s86-s102
Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers
Clinical Liver Disease. 2012;1(4):104-107
Introductory Chapter: Nonalcoholic Fatty Liver Disease - What Should We Know?
Nonalcoholic Fatty Liver Disease - An Update. 2019;
Implications of comorbidities in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology. 2023;29(2):384-389
The Rise in the Prevalence of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
Nonalcoholic Fatty Liver Disease - An Update. 2019;
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) patients with advanced liver disease had high burden of comorbidities, healthcare resource utilization (HCRU) and costs: results from Italian administrative databases
Digestive and Liver Disease. 2019;51:e27
Natural history of nonalcoholic fatty liver disease
Clinical Liver Disease. 2012;1(4):112-113